1. Home
  2. NBN vs COLL Comparison

NBN vs COLL Comparison

Compare NBN & COLL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Northeast Bank

NBN

Northeast Bank

HOLD

Current Price

$126.94

Market Cap

1.1B

Sector

Finance

ML Signal

HOLD

Logo Collegium Pharmaceutical Inc.

COLL

Collegium Pharmaceutical Inc.

HOLD

Current Price

$27.05

Market Cap

1.2B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
NBN
COLL
Founded
1872
2002
Country
United States
United States
Employees
234
N/A
Industry
Major Banks
Biotechnology: Pharmaceutical Preparations
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
1.1B
1.2B
IPO Year
N/A
2015

Fundamental Metrics

Financial Performance
Metric
NBN
COLL
Price
$126.94
$27.05
Analyst Decision
Buy
Strong Buy
Analyst Count
2
5
Target Price
$130.50
$51.40
AVG Volume (30 Days)
87.6K
744.4K
Earning Date
04-27-2026
05-07-2026
Dividend Yield
0.03%
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
$780,567,000.00
Revenue This Year
$13.77
$8.01
Revenue Next Year
$18.72
N/A
P/E Ratio
$11.29
N/A
Revenue Growth
N/A
23.62
52 Week Low
$80.75
$25.47
52 Week High
$142.31
$50.79

Technical Indicators

Market Signals
Indicator
NBN
COLL
Relative Strength Index (RSI) 46.74 33.30
Support Level $127.84 $25.47
Resistance Level $137.72 $35.89
Average True Range (ATR) 2.86 1.18
MACD -0.60 0.04
Stochastic Oscillator 16.69 40.19

Price Performance

Historical Comparison
NBN
COLL

About NBN Northeast Bank

Northeast Bank provides banking and financial services to individual and corporate customers in the United States. The firm conducts its loan-related activities through two primary channels: the Community Banking Division, and the Small Business Administration (SBA) National Division. Its loan portfolio comprises residential mortgage loans; multi-family and other commercial real estate loans; commercial and industrial loans, consumer loans, and small business administration loans. The firm also provides telephone banking, online banking, mobile banking, and remote deposit capture services. The revenue of the company is derived principally from interest and dividends from the bank.

About COLL Collegium Pharmaceutical Inc.

Collegium Pharmaceutical Inc is a diversified biopharmaceutical company committed to improving the lives of people living with serious medical conditions. The company has developed, licensed, and acquired a portfolio of meaningfully differentiated products for the treatment of attention deficit hyperactivity disorder (ADHD) and moderate to severe pain. It commercializes its products in the United States, including Jornay PM, Belbuca, Xtampza ER, Nucynta ER, Nucynta IR (collectively, the Nucynta Products), and Symproic. The company's product portfolio includes Jornay PM, Belbuca, Xtampza ER, Nucynta IR, Nucynta ER, and Symproic.

Share on Social Networks: